US › Healthcare

Cumberland Pharmaceuticals Inc (CPIX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.77+8.22%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$9.1M
Revenue YoY
-22.0%
Net profit
$-3.1M
Profit YoY
-349.7%
EPS
$-0.22
EPS estimate
$0.00
Net margin
-34.4%

Key statistics

Market cap
$100.1M
Forward P/E
50.0
P/B
4.66
Book value
$1.44
EPS (TTM)
$-0.49
52-week high
$7.21
52-week low
$1.13
50-day MA
$6.27
200-day MA
$4.21
Beta
0.10

Analyst view

Analysts rate Cumberland Pharmaceuticals Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $8.50.

Shareholding

Insiders
41.60%
Institutions
18.65%

Largest institutional holders

FundStake
Ikarian Capital, LLC3.69%
Renaissance Technologies Corp3.14%
Vanguard Capital Management, LLC2.41%
Dimensional Fund Advisors, Inc.1.84%
Perceptive Advisors LLC1.31%
Bridgeway Capital Management, LLC1.09%
BOOTHBAY FUND MANAGEMENT, LLC0.85%
Geode Capital Management, LLC0.76%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cumberland Pharmaceuticals Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.